This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Fortrea Securities Fraud Class Action
Business class action

Fortrea Securities Fraud Class Action

Analysis based on 22 articles · First reported Jun 06, 2025 · Last updated Jul 20, 2025

Sentiment
-70
Attention
4
Articles
22
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Fortrea, coupled with its disappointing financial results and a critical report from Jefferies, has led to significant declines in Fortrea's stock price. This event highlights the risks associated with spin-offs and potential misrepresentations of financial projections, impacting investor confidence in Fortrea and potentially other companies undergoing similar transitions.

Pharmaceuticals Biotechnology Legal Services
Event Summary

A class action lawsuit has been filed against Fortrea and its senior executives by Bleichmar Fonti & Auld LLP, alleging violations of federal securities laws. The lawsuit claims that Fortrea overstated the cost savings and margin improvements from exiting transition services agreements with Labcorp, as well as the revenue from pre-spin projects. This alleged misrepresentation led to a significant decline in Fortrea's stock price, including a 12% drop after a Jefferies report on September 25, 2024, and a further 25% decline on March 3, 2025, following the announcement of disappointing Q4 and full year 2024 financial results. The case is pending in the United States — United States District Court for the Northern District of California, with investors having until August 1, 2025, to seek appointment as lead plaintiff.

Key Actions
100 Bleichmar Fonti & Auld LLP filed lawsuit Fortrea
93 Fortrea announced financial results
90 Fortrea overstated cost savings
70 Jefferies published report Fortrea
60 Fortrea spun off Labcorp
50 Fortrea entered into agreements Labcorp
Entities Involved
stock
Fortrea
Fortrea is the defendant in a securities fraud class action lawsuit, accused of overstating cost savings and revenue projections, leading to significant stock price declines.
Importance 100.0 Sentiment -80.0
priv
Jefferies
Jefferies published a report on September 25, 2024, questioning Fortrea's projected cost savings, which contributed to a stock price decline.
Importance 70.0 Sentiment 0.0
stock
Labcorp
Labcorp spun off Fortrea in June 2023 and entered into transition services agreements with Fortrea, which are central to the alleged misrepresentations.
Importance 60.0 Sentiment 0.0
govactor
United States — United States District Court for the Northern District of California
Importance 0.0 Sentiment 0.0
priv
Bleichmar Fonti & Auld LLP
Importance 0.0 Sentiment 0.0
Relationships
United States — United States District Court for the Northern District of California related ↔ Bleichmar Fonti & Auld LLP
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.